Navigation Links
Premier Research Names Bernard Sweeney as Executive Director, Medical Devices
Date:10/20/2009

PHILADELPHIA, Oct. 20 /PRNewswire/ -- Premier Research Group Limited, the international pharmaceutical and medical device services company, announces the appointment of Bernard Sweeney as Executive Director, Medical Devices. In this position, Mr. Sweeney will play a leading role in the operations, strategic planning, and corporate development of Premier Research's growing portfolio of medical device business. He will be based in Premier Research's Swiss office.

Mr. Sweeney has more than 20 years experience in medical device research and development, during which time he has supervised clinical trials leading to the market approval of more than 20 new products. He joins us from the British Standards Institute (BSi) where he had been the Director of Healthcare responsible for providing global regulatory approvals leading to market access for medical device companies across the world. Prior to his time at BSi, Mr. Sweeney held positions at both government agencies and medical devices manufacturers including Medilink East Midlands and Femcare Nikomed Group.

"Mr. Sweeney is an exceptional addition to our team," said Chris Nowell, Vice President, International Clinical Trial Management. "As we continue to expand our presence within the medical device market, Mr. Sweeney's substantial clinical and management expertise will be beneficial in continuing to establish Premier Research as the industry leader."

About Premier Research

Premier Research is a leading global solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia, neuroscience, oncology, and infectious disease and have a wealth of experience in medical device and pediatric research.

Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1,200 clinical professionals dedicated first and foremost to fulfilling each client's requirements in a timely, accurate, and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at our well-established network of dedicated clinical sites.

www.premier-research.com

SOURCE Premier Research Group Limited


'/>"/>
SOURCE Premier Research Group Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Micronutrient Launches Supplement for Hearing Health
2. CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year
3. Groundbreaking American Journal of Play from Strong National Museum of Play(R) Premiers July 2008
4. Premier Research Honored as Clinical Research Team of the Year at 2008 GCPj Awards
5. Premier Research Announces Milestone New Drug Application
6. Premier Research Expands its Medical Device Operations to the United States
7. Premier Research Announces Milestone Investigational New Drug Application
8. Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
9. Premier Heart Launches Multifunction CardioGram(TM) (MCG) In Latin America and the Caribbean
10. Premier Research Appoints Troy W. McCall, Ph.D. as Chief Executive Officer
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com report ... been growing rapidly as the global sales of Adcetris and Kadcyla ... in the antibody drug conjugates market is driven by large number ... and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 ...
(Date:3/24/2017)...  GenomeDx Biosciences today announced that six abstracts featuring ... Cancer Classifier tests will be presented at the 32 ... held March 24 to 28, 2017 in ... Europe,s largest urological event showcasing ... field. The abstract titled "Muscle invasive bladder ...
(Date:3/24/2017)... 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today disclosed terms ... Sheet (the "Definitive Financing") it entered into on ... stockholders, who are referred to in the Definitive ... filed with the Securities and Exchange Commission.   ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... 2017 , ... As the standards bearer of advanced cancer ... positions them as the go-to thought leader in all matters concerning oncology nursing. ... always-on, always-fresh news, views and advocacy engine, called ONS Voice. , The ONS ...
(Date:3/24/2017)... Westchester County, NY (PRWEB) , ... March 24, 2017 , ... ... in Somers and White Plains, N.Y., is pleased to announce Westchester resident Lauren C. ... as a law clerk for the firm, will concentrate her practice in elder law, ...
(Date:3/24/2017)... ... 24, 2017 , ... Empower Brokerage, located in Southlake, Texas, ... programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program ... to teach how to maximize their sales efforts, as well as how to ...
(Date:3/24/2017)... ... ... Time GPS”: a dauntless and enlightened study of the second-coming of Christ, and ... published author, Wesley Gerboth, a World War II veteran, with a highly-regarded reputation as ... ninety-one, he shares the Wisdom God bestowed upon him in this publication. , ...
(Date:3/24/2017)... , ... March 24, 2017 , ... “The Adventures of ... smart and silly dog who lives his life to the fullest, as God intended. ... published author Patti Holmgren, a mother and grandmother pursuing her passion for writing, especially ...
Breaking Medicine News(10 mins):